Group One Trading, L.P. Cytokinetics Inc Transaction History

Group One Trading, L.P.

$2.2 Billion
Q1 2025

A detailed history of Group One Trading, L.P. transactions in Cytokinetics Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 204,512 shares of CYTK stock, worth $6.56 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

204,512

Holding current value

$6.56 Million

% of portfolio

0.37%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$40.19 - $51.12 $8.22 Million - $10.5 Million	204,512 New	204,512 $8.22 Million
Q3 2023 Nov 09, 2023	SELL	$29.46 - $36.61 $77,155 - $95,881	-2,619 Reduced 15.7%	14,059 $414,000
Q2 2023 Aug 09, 2023	BUY	$32.62 - $40.75 $544,036 - $679,628	16,678 New	16,678 $544,000
Q4 2022 Feb 09, 2023	BUY	$35.77 - $51.11 $100,978 - $144,283	2,823 Added 131.06%	4,977 $228,000
Q3 2022 Nov 09, 2022	BUY	$38.54 - $54.52 $83,015 - $117,436	2,154 New	2,154 $104,000
Q2 2022 Aug 11, 2022	SELL	$33.93 - $48.92 $358,979 - $517,573	-10,580 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$29.74 - $46.0 $2.19 Million - $3.39 Million	-73,640 Reduced 87.44%	10,580 $389,000
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $2.89 Million - $3.91 Million	84,220 New	84,220 $3.84 Million
Q3 2021 Nov 12, 2021	SELL	$18.54 - $35.74 $935,435 - $1.8 Million	-50,455 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$19.79 - $26.99 $363,700 - $496,022	18,378 Added 57.29%	50,455 $999,000
Q1 2021 May 12, 2021	BUY	$18.57 - $25.68 $20,965 - $28,992	1,129 Added 3.65%	32,077 $746,000
Q4 2020 Feb 10, 2021	BUY	$15.26 - $28.61 $164,487 - $308,387	10,779 Added 53.44%	30,948 $643,000
Q3 2020 Nov 12, 2020	BUY	$20.58 - $28.96 $415,078 - $584,094	20,169 New	20,169 $437,000
Q4 2019 Feb 10, 2020	SELL	$7.95 - $11.84 $5,469 - $8,145	-688 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$10.82 - $14.25 $28,424 - $37,434	-2,627 Reduced 79.25%	688 $8,000
Q2 2019 Aug 09, 2019	BUY	$7.95 - $11.25 $14,365 - $20,328	1,807 Added 119.83%	3,315 $37,000
Q1 2019 May 13, 2019	BUY	$5.95 - $10.19 $8,972 - $15,366	1,508 New	1,508 $12,000
Q4 2018 Feb 06, 2019	SELL	$5.91 - $9.29 $220,277 - $346,256	-37,272 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$6.4 - $9.85 $124,428 - $191,503	-19,442 Reduced 34.28%	37,272 $367,000
Q2 2018 Aug 14, 2018	BUY	$6.9 - $9.9 $149,481 - $214,473	21,664 Added 61.81%	56,714 $471,000
Q1 2018 May 11, 2018	BUY	$7.2 - $10.05 $40,939 - $57,144	5,686 Added 19.36%	35,050 $252,000
Q4 2017 Feb 09, 2018	SELL	$7.25 - $15.65 $266,024 - $574,245	-36,693 Reduced 55.55%	29,364 $239,000
Q3 2017 Nov 15, 2017	BUY	$12.0 - $15.0 $465,564 - $581,955	38,797 Added 142.32%	66,057 $958,000
Q2 2017 Aug 14, 2017	BUY	N/A	27,260	27,260 $330,000

Others Institutions Holding CYTK

# of Institutions

408

Shares Held

127M

Call Options Held

3.66M

Put Options Held

900K

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.02B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Cytokinetics Inc Transaction History